W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed every 4 ...

Medically reviewed by Andrew Greenberg, MD Key Takeaways Macular edema is swelling in the retina that can cause blurry vision and vision loss.Macular edema can be treated with medications like NSAID ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that can be refilled every six months instead of requiring monthly injections. Diabetic macular edema affects about 5% to 7% of people ...

“Our findings demonstrate that a simple oral pill can effectively target and repair the inner blood-retina barrier. This ...

An experimental eye injection developed by Merck has met its main goal in a clinical trial involving patients with diabetic ...

People with diabetic macular edema may receive eye injections to help control their symptoms. These shots can help to improve vision and also stop the damage that causes vision issues to get worse.

MISSISSAUGA, ON, Aug. 29, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) is now publicly funded for macular edema secondary to ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies ...

Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ...

(A) The en-face view of cystoid edema in DCP segmentation. (B) The contour of cysts was precisely delineated from the surrounding tissue using ImageJ software with an appropriate threshold, and the ...

Vabysmo now covered across all three approved indications in the province, providing patients with a comprehensively funded option for their needs MISSISSAUGA, ON, Aug. 15, 2025 /CNW/ - Hoffmann-La ...